Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
AZN
AZN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AZN News
Pictet North America Advisors Increases Stake in MercadoLibre
5d ago
Fool
AbbVie Ventures into Weight Loss Market with Promising Drug
5d ago
Fool
Rapid Growth of GLP-1 Drug Market
6d ago
NASDAQ.COM
Parnassus Value Equity Fund's Q1 2026 Strategic Investment Moves
Apr 10 2026
Yahoo Finance
Research Reports on AstraZeneca, HSBC, and Disney Highlight Market Trends
Apr 07 2026
NASDAQ.COM
FDA Approves First Generic Versions of Farxiga Diabetes Drug
Apr 07 2026
seekingalpha
UK and US Reach Drug Tariff Exemption Agreement
Apr 02 2026
seekingalpha
AstraZeneca's Imfinzi Shows Success in Liver Cancer Trial
Apr 02 2026
seekingalpha
AstraZeneca Reports Positive Results from Liver Cancer Trial
Apr 02 2026
NASDAQ.COM
AstraZeneca's Investment Outlook for 2026
Apr 02 2026
Yahoo Finance
AstraZeneca's efzimfotase alfa Phase III Trials Show Positive Results
Mar 31 2026
NASDAQ.COM
AstraZeneca Reports 8% Revenue Growth for FY2025 Driven by Oncology
Mar 30 2026
Yahoo Finance
FDA Accelerates Biosimilar Drug Development and Approves New Treatments
Mar 30 2026
NASDAQ.COM
AstraZeneca's Antibody Therapy Achieves Phase 3 Trial Success
Mar 27 2026
seekingalpha
First IL-33-Targeting Biologic Shows Significant Reduction in COPD Exacerbations
Mar 27 2026
Newsfilter
AstraZeneca Reports Positive COPD Trial Results
Mar 27 2026
NASDAQ.COM
Show More News
